Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biomarkers for Alzheimer's disease: current status and prospects for the future
Kaj Blennow, Henrik Zetterberg
Journal of Internal Medicine (2018) Vol. 284, Iss. 6, pp. 643-663
Open Access | Times Cited: 779

Showing 1-25 of 779 citing articles:

Biomarkers for neurodegenerative diseases
Oskar Hansson
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 954-963
Open Access | Times Cited: 741
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease
Sahil Khan, Kalyani Barve, Maushmi S. Kumar
Current Neuropharmacology (2020) Vol. 18, Iss. 11, pp. 1106-1125
Open Access | Times Cited: 530
TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge
Alicia Nugent, Karin Lin, Bettina van Lengerich, et al.
Neuron (2020) Vol. 105, Iss. 5, pp. 837-854.e9
Open Access | Times Cited: 519
Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology
Nicholas J. Ashton, Tharick A. Pascoal, Thomas K. Karikari, et al.
Acta Neuropathologica (2021) Vol. 141, Iss. 5, pp. 709-724
Open Access | Times Cited: 473
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
Gaël Chételat, Javier Arbizu, Henryk Barthel, et al.
The Lancet Neurology (2020) Vol. 19, Iss. 11, pp. 951-962
Open Access | Times Cited: 404
Diagnosis of Early Alzheimer’s Disease: Clinical Practice in 2021
Anton P. Porsteinsson, Richard Isaacson, S. Knox, et al.
The Journal of Prevention of Alzheimer s Disease (2021), pp. 1-16
Open Access | Times Cited: 397
A multicentre validation study of the diagnostic value of plasma neurofilament light
Nicholas J. Ashton, Shorena Janelidze, Ahmad Al Khleifat, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 387
Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease
Lenora Higginbotham, Lingyan Ping, Eric B. Dammer, et al.
Science Advances (2020) Vol. 6, Iss. 43
Open Access | Times Cited: 286
A walk through tau therapeutic strategies
Santosh Jadhav, Jesús Ávila, Michael Schöll, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 248
A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer’s disease
Shaker El–Sappagh, José M. Alonso, S. M. Riazul Islam, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 236
Developing the ATX(N) classification for use across the Alzheimer disease continuum
Harald Hampel, Jeffrey L. Cummings, Kaj Blennow, et al.
Nature Reviews Neurology (2021) Vol. 17, Iss. 9, pp. 580-589
Closed Access | Times Cited: 235
The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
Ashwinipriyadarshini Megur, Daiva Baltriukienė, Virginija Bukelskienė, et al.
Nutrients (2020) Vol. 13, Iss. 1, pp. 37-37
Open Access | Times Cited: 231
Blood biomarkers for Alzheimer’s disease in clinical practice and trials
Oskar Hansson, Kaj Blennow, Henrik Zetterberg, et al.
Nature Aging (2023) Vol. 3, Iss. 5, pp. 506-519
Open Access | Times Cited: 227
The inter-relationship between delirium and dementia: the importance of delirium prevention
Tamara G. Fong, Sharon K. Inouye
Nature Reviews Neurology (2022) Vol. 18, Iss. 10, pp. 579-596
Open Access | Times Cited: 207
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 156
A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury
Eric Peter Thelin, Faiez Al Nimer, Arvid Frostell, et al.
Journal of Neurotrauma (2019) Vol. 36, Iss. 20, pp. 2850-2862
Open Access | Times Cited: 151
Early-Onset Alzheimer’s Disease: What Is Missing in Research?
Temitope Ayodele, Ekaterina Rogaeva, Jiji T. Kurup, et al.
Current Neurology and Neuroscience Reports (2021) Vol. 21, Iss. 2
Open Access | Times Cited: 142
Alzheimer’s Disease: Key Insights from Two Decades of Clinical Trial Failures
C. Kwon Kim, Yin Rui Lee, Lynnett Ong, et al.
Journal of Alzheimer s Disease (2022) Vol. 87, Iss. 1, pp. 83-100
Open Access | Times Cited: 126
Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs
Ana Rita Monteiro, Daniel José Barbosa, Fernando Remião, et al.
Biochemical Pharmacology (2023) Vol. 211, pp. 115522-115522
Open Access | Times Cited: 121
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers
Nicholas J. Ashton, Antoine Leuzy, Thomas K. Karikari, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 7, pp. 2140-2156
Open Access | Times Cited: 105
Aducanumab Therapy to Treat Alzheimer’s Disease: A Narrative Review
Semira Abdi Beshir, Aadith Soorya, Affana Parveen, et al.
International Journal of Alzheimer s Disease (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 83
Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Angelica Varesi, Adelaide Carrara, Vitor Gomes Pires, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1367-1367
Open Access | Times Cited: 78
Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment
Giulia Giacomucci, Salvatore Mazzeo, Silvia Bagnoli, et al.
Journal of Neurology (2022) Vol. 269, Iss. 8, pp. 4270-4280
Open Access | Times Cited: 74
Blood-based biomarkers in Alzheimer’s disease – moving towards a new era of diagnostics
Burak Arslan, Henrik Zetterberg, Nicholas J. Ashton
Clinical Chemistry and Laboratory Medicine (CCLM) (2024) Vol. 62, Iss. 6, pp. 1063-1069
Open Access | Times Cited: 25
Digital Neuropsychology beyond Computerized Cognitive Assessment: Applications of Novel Digital Technologies
Che Harris, Yingfei Tang, Eliana Birnbaum, et al.
Archives of Clinical Neuropsychology (2024) Vol. 39, Iss. 3, pp. 290-304
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top